Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014912-36Phase 2Terminated
Phase 2, open-label, single-arm trial of simvastatin in Langerhans cell histiocytosis (LCH), sponsored by Karolinska Institutet. Primary endpoints: Treatment outcome evaluation and Clinical and laboratory monitoring. Started Jul 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014912-36.